Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Stifel analyst Drew Crum raised the firm’s price target on Take-Two (TTWO) to $223 from $220 and keeps a Buy rating on the shares. The firm ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...

Brian Gardner, Stifel chief Washington policy strategist, joins 'Closing Bell Overtime' to talk how to play the Trump trade ...

Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...